India · Delayed Price · Currency is INR Mangalam Drugs & Organics Statistics
Total Valuation
BOM:532637 has a market cap or net worth of INR 464.08 million. The enterprise value is 1.36 billion.
| Market Cap | 464.08M |
| Enterprise Value | 1.36B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:532637 has 15.83 million shares outstanding. The number of shares has increased by 0.03% in one year.
| Current Share Class | 15.83M |
| Shares Outstanding | 15.83M |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | 23.34% |
| Owned by Institutions (%) | n/a |
| Float | 9.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.18 |
| PB Ratio | 0.53 |
| P/TBV Ratio | 0.83 |
| P/FCF Ratio | 3.88 |
| P/OCF Ratio | 2.34 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 11.38 |
Financial Position
The company has a current ratio of 0.74, with a Debt / Equity ratio of 1.03.
| Current Ratio | 0.74 |
| Quick Ratio | 0.17 |
| Debt / Equity | 1.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | 7.56 |
| Interest Coverage | -2.25 |
Financial Efficiency
Return on equity (ROE) is -35.36% and return on invested capital (ROIC) is -12.31%.
| Return on Equity (ROE) | -35.36% |
| Return on Assets (ROA) | -4.93% |
| Return on Invested Capital (ROIC) | -12.31% |
| Return on Capital Employed (ROCE) | -24.17% |
| Weighted Average Cost of Capital (WACC) | 8.24% |
| Revenue Per Employee | 8.21M |
| Profits Per Employee | -1.19M |
| Employee Count | 319 |
| Asset Turnover | 0.85 |
| Inventory Turnover | 1.65 |
Taxes
| Income Tax | -7.41M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.60% in the last 52 weeks. The beta is 0.31, so BOM:532637's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | -55.60% |
| 50-Day Moving Average | 31.04 |
| 200-Day Moving Average | 30.74 |
| Relative Strength Index (RSI) | 45.92 |
| Average Volume (20 Days) | 2,501 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532637 had revenue of INR 2.62 billion and -381.02 million in losses. Loss per share was -24.07.
| Revenue | 2.62B |
| Gross Profit | 865.29M |
| Operating Income | -242.44M |
| Pretax Income | -388.43M |
| Net Income | -381.02M |
| EBITDA | -101.46M |
| EBIT | -242.44M |
| Loss Per Share | -24.07 |
Balance Sheet
The company has 8.35 million in cash and 903.89 million in debt, with a net cash position of -895.54 million or -56.58 per share.
| Cash & Cash Equivalents | 8.35M |
| Total Debt | 903.89M |
| Net Cash | -895.54M |
| Net Cash Per Share | -56.58 |
| Equity (Book Value) | 879.29M |
| Book Value Per Share | 55.50 |
| Working Capital | -521.74M |
Cash Flow
In the last 12 months, operating cash flow was 198.36 million and capital expenditures -78.85 million, giving a free cash flow of 119.51 million.
| Operating Cash Flow | 198.36M |
| Capital Expenditures | -78.85M |
| Depreciation & Amortization | 194.14M |
| Net Borrowing | 218.68M |
| Free Cash Flow | 119.51M |
| FCF Per Share | 7.55 |
Margins
Gross margin is 33.03%, with operating and profit margins of -9.25% and -14.54%.
| Gross Margin | 33.03% |
| Operating Margin | -9.25% |
| Pretax Margin | -14.83% |
| Profit Margin | -14.54% |
| EBITDA Margin | -3.87% |
| EBIT Margin | -9.25% |
| FCF Margin | 5.15% |
Dividends & Yields
BOM:532637 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.03% |
| Shareholder Yield | -0.03% |
| Earnings Yield | -82.10% |
| FCF Yield | 25.75% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |